Zenotech Laboratories Ltd
NSE: BSE: 532039
₹42.84
(2.00%)
Wed, 18 Mar 2026, 00:03 am
Market Cap2.56B
PE Ratio79.03
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KZenotech Laboratories Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 123.72M | 128.29M | 82.36M | 60.23M | 65.23M | 70.01M | 17.41M | 30.44M | 27.56M | 40.77M | 20.60M | 22.54M | 111.44M | 130.29M | 259.38M | 193.73M | 324.94M | 383.53M | 367.62M | 389.76M |
| Gross profit | -24.47M | -70.43M | -77.36M | -138.85M | -97.74M | -113.83M | -51.43M | -111.70M | -157.29M | -90.91M | -81.36M | -112.43M | -80.48M | -51.89M | 59.15M | -12.83M | 90.51M | 122.26M | 93.53M | 73.12M |
| Operating expenses (excl. COGS) | -4.64M | -12.89M | -52.25M | -73.07M | -34.62M | -34.81M | -36.17M | -126.67M | -24.95M | -148.69M | -34.78M | -30.10M | -37.10M | -24.05M | -18.67M | -18.65M | -25.90M | -26.36M | -30.95M | -38.97M |
| Selling/general/admin expenses, total | — | — | -49.70M | -71.24M | -27.51M | -32.56M | -32.48M | -89.80M | -37.24M | -41.88M | -17.89M | -13.50M | -20.00M | -14.32M | -15.35M | -15.93M | -22.32M | -23.62M | -28.20M | -32.94M |
| Research & development | -3.93M | -1.85M | -2.17M | -13.81M | -8.12M | -12.06M | -8.74M | -25.86M | -15.46M | 0 | 0 | — | — | — | 0 | — | — | — | — | — |
| Selling/general/admin expenses, other | — | — | -47.53M | -57.43M | -19.39M | -20.50M | -23.74M | -63.95M | -21.78M | -41.88M | -17.89M | -13.50M | -20.00M | -14.32M | -15.35M | -15.93M | -22.32M | -23.62M | -28.20M | -32.94M |
| Other operating expenses, total | -4.64M | -12.89M | -2.55M | -1.83M | -7.11M | -2.25M | -3.69M | -36.87M | 12.29M | -106.81M | -16.89M | -16.60M | -17.10M | -9.74M | -3.32M | -2.72M | -3.58M | -2.74M | -2.75M | -6.02M |
| Operating income | -29.11M | -83.32M | -129.62M | -211.92M | -132.36M | -148.63M | -87.60M | -238.38M | -182.24M | -239.60M | -116.14M | -142.53M | -117.58M | -75.95M | 40.48M | -31.48M | 64.61M | 95.90M | 62.59M | 34.16M |
| Non-operating income, total | -4.97M | 71.55M | -6.42M | 36.28M | 6.91M | -229.75M | -15.02M | -16.84M | -46.31M | -64.54M | -75.23M | -56.16M | -927.00K | 44.68M | 67.30M | 19.33M | 34.40M | 49.12M | 48.83M | 72.76M |
| Interest expense, net of interest capitalized | -5.86M | -21.51M | -28.00M | -20.55M | -16.31M | -7.98M | -4.83M | -14.68M | -46.86M | -66.53M | -75.46M | -75.00M | -24.49M | -1.18M | -8.93M | -15.47M | -12.15M | -1.12M | 0 | 0 |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.26K | 2.63K | 2.63K | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 891.00K | 93.06M | 21.58M | 62.43M | 23.22M | 8.33M | 5.54M | -741.00K | 550.00K | 909.00K | -99.00K | 497.00K | 18.08M | 13.17M | 11.39M | 31.90M | 45.77M | 50.04M | 48.71M | 53.36M |
| Non-operating interest income | 696.00K | 1.98M | 20.06M | 44.30M | 19.89M | 7.65M | 1.18M | 1.17M | 3.67M | 2.23M | 2.06M | 226.00K | 17.31M | 12.48M | 9.37M | 547.00K | 986.00K | 3.69M | 9.45M | 14.09M |
| Miscellaneous non-operating expense | 195.00K | 91.08M | 1.52M | 18.13M | 3.33M | 687.00K | 4.36M | -1.91M | -3.12M | -1.32M | -2.16M | 271.00K | 770.00K | 684.00K | 2.02M | 31.35M | 44.79M | 46.36M | 39.26M | 39.27M |
| Unusual income/expense | — | — | — | -5.60M | — | -230.10M | -15.73M | -1.43M | — | 1.08M | 331.00K | 18.35M | 5.49M | 32.69M | 64.83M | 2.91M | 779.00K | 200.00K | 116.00K | 19.40M |
| Pretax income | -34.07M | -11.77M | -136.04M | -175.64M | -125.45M | -378.38M | -102.62M | -255.22M | -228.55M | -304.14M | -191.37M | -198.69M | -118.51M | -31.27M | 107.78M | -12.15M | 99.01M | 145.02M | 111.41M | 106.92M |
| Taxes | -1.94M | 28.26M | -22.91M | 0 | 203.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 122.75M | -29.17M | -28.43M | -50.79M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | -17.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -36.01M | 16.46M | -158.94M | -175.64M | -125.25M | -378.38M | -102.62M | -255.22M | -228.55M | -304.14M | -191.37M | -198.69M | -118.51M | -31.27M | 107.78M | -12.15M | 221.76M | 115.85M | 82.99M | 56.13M |
| Net income | -36.01M | 16.46M | -158.94M | -175.64M | -125.25M | -378.38M | -102.62M | -255.22M | -228.55M | -304.14M | -191.37M | -198.69M | -118.51M | -31.27M | 107.78M | -12.15M | 221.76M | 115.85M | 82.99M | 56.13M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -36.01M | 16.46M | -158.94M | -175.64M | -125.25M | -378.38M | -102.62M | -255.22M | -228.55M | -304.14M | -191.37M | -198.69M | -118.51M | -31.27M | 107.78M | -12.15M | 221.76M | 115.85M | 82.99M | 56.13M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -16.55M | -55.74M | -85.98M | -169.21M | -87.45M | -98.02M | -52.67M | -203.23M | -146.68M | -199.04M | -76.52M | -103.79M | -78.55M | -33.93M | 88.97M | 33.08M | 134.35M | 167.63M | 133.44M | 103.76M |
| EBIT | -29.11M | -83.32M | -129.62M | -211.92M | -132.36M | -148.63M | -87.60M | -238.38M | -182.24M | -239.60M | -116.14M | -142.53M | -117.58M | -75.95M | 40.48M | -31.48M | 64.61M | 95.90M | 62.59M | 34.16M |
| Total operating expenses | -152.83M | -211.61M | -211.97M | -272.16M | -197.59M | -218.65M | -105.01M | -268.82M | -209.80M | -280.37M | -136.74M | -165.07M | -229.03M | -206.24M | -218.91M | -225.21M | -260.33M | -287.63M | -305.03M | -355.60M |
| Prepaid expenses | 930.00K | 24.64M | 7.56M | 17.01M | 20.01M | 20.92M | 99.00K | 224.00K | 442.00K | 319.00K | 275.00K | 417.00K | 449.00K | 586.00K | 697.00K | 825.00K | 3.84M | 3.22M | 1.39M | 2.95M |
| Deferred income, current | — | — | — | — | — | — | — | — | 1.08M | — | — | 128.48M | 77.79M | — | — | — | — | — | — | — |
| Capital and operating lease obligations | 2.71M | 2.77M | — | 1.73M | 1.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 6.11M | 66.62M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 81.32M | 77.39M | 89.78M | 85.40M |
| Deferred income, non-current | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | 0 | 0 | — | — | — | — | — | — | 221.00K | 38.00K | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800